Core Viewpoint - BrainCo (06681) has signed a strategic cooperation agreement with Kiang Wu Hospital in Macau to develop a comprehensive brain health service model focusing on cognitive impairment screening, assessment, training, and health management [1][4]. Group 1: Company Developments - BrainCo's stock price increased by 3.89%, reaching HKD 4.81, with a trading volume of HKD 71.89 million [1][4]. - The agreement with Kiang Wu Hospital aims to establish a long-term strategic partnership in Macau, creating a full-chain brain health service model that integrates hospitals, communities, and home care [1][4].

Core Viewpoint - The company has signed a strategic cooperation agreement with Macau's Kiang Wu Hospital to establish a comprehensive brain health service model, focusing on cognitive impairment screening, assessment, training, and health management in the Macau region [1][2]. Group 1: Cooperation Details - The collaboration will involve the establishment of a "Brain Health Center" within Kiang Wu Hospital, providing a one-stop service from early screening to digital cognitive training and follow-up management [1]. - The services will cater to all age groups, including individuals aged 60 and above at risk of cognitive impairment and children aged 3 to 18 with neurodevelopmental disorders, offering both in-hospital and home-based digital therapy [1]. - Data security and compliance will be ensured by localizing data storage and processing in accordance with Macau's laws, preventing data from being transmitted outside the region [1]. Group 2: Strategic Significance - This partnership is expected to set a benchmark and expand the company's market presence in the Greater Bay Area, serving as a model for future projects in other cities [2]. - The collaboration aims to accumulate high-quality real-world data for further scientific research on cognitive function diseases, enhancing diagnostic services and product development [2]. - The initiative addresses the urgent health needs in Macau, potentially reducing the incidence of severe dementia and providing sustainable service revenue for the company [2]. Group 3: Academic and Research Collaboration - The partnership will enhance the company's ecosystem by integrating resources from mainland and Macau experts, promoting the construction of a brain health medical center and related clinical research [2][3]. - This collaboration aligns with the company's recent national-level project with the Ministry of Civil Affairs, fostering the standardization and large-scale application of cognitive digital therapies [3].

Core Viewpoint - The company has signed a strategic cooperation agreement with Kiang Wu Hospital in Macau to establish a comprehensive brain health service model, focusing on digital screening, assessment, training, and health management for cognitive disorders. Group 1: Cooperation Details - The partnership will create a "Brain Health Center" within Kiang Wu Hospital, offering a one-stop service from early screening to digital cognitive training and follow-up care [1] - Services will cater to all age groups, including individuals aged 60 and above at risk of cognitive disorders and children aged 3 to 18 with neurodevelopmental disorders, providing both in-hospital and home-based digital therapy [1] - Data generated from the services will comply with local laws and regulations, ensuring data security and local storage without cross-border transmission [1] Group 2: Strategic Significance - The collaboration establishes a benchmark project for the company's digital therapy in the Hong Kong-Macau region, facilitating future expansion in the Greater Bay Area [2] - The partnership aims to accumulate high-quality real-world data for further scientific research on cognitive function diseases, enhancing diagnostic services and product iterations [2] - The initiative addresses urgent health needs in Macau, potentially reducing the incidence of severe dementia and creating sustainable service revenue for the company [2] Group 3: Academic and Research Collaboration - The cooperation enriches the company's ecosystem by integrating resources from authoritative medical institutions, promoting the standardization and large-scale application of cognitive digital therapies [3]